#Nabota

Yonhap Infomax Newsinfomaxkorea
2026-01-30

Daewoong Pharmaceutical Co., Ltd. has signed a 29.5 billion won ($22.2 million) export deal with M8 (Moksha8) to supply its botulinum toxin Nabota to Mexico, expanding its reach across Latin America's top five aesthetic markets and highlighting significant growth potential in the region.

en.infomaxai.com/news/articleV

Yonhap Infomax Newsinfomaxkorea
2025-09-29

Daewoong Pharmaceutical has expanded its botulinum toxin Nabota to 10 Middle Eastern countries, securing new export deals with Iraq and Bahrain as part of its broader MENA strategy.

en.infomaxai.com/news/articleV

Yonhap Infomax Newsinfomaxkorea
2025-08-26

Daewoong Pharmaceutical signed a 34.1 billion won ($25.8 million) export deal with Colombia's Valentech Pharma for Nabota, aiming for a 30% market share in the Latin American aesthetics market within five years.

en.infomaxai.com/news/articleV

Yonhap Infomax Newsinfomaxkorea
2025-07-30

Daewoong Pharmaceutical has voluntarily withdrawn its application for Nabota's 100-unit product approval in China, aiming to resubmit with expanded dosage options to meet regulatory and market demands.

en.infomaxai.com/news/articleV

Yonhap Infomax Newsinfomaxkorea
2025-06-19

Daewoong Pharmaceutical signed a record 73.8 billion won export deal for its botulinum toxin Nabota with Thailand's Montana Marketing, marking its largest Southeast Asian contract to date.

en.infomaxai.com/news/articleV

Client Info

Server: https://mastodon.social
Version: 2025.07
Repository: https://github.com/cyevgeniy/lmst